A Research Study on How Well Semaglutide Works in Adolescents With Overweight or Obesity

PHASE3CompletedINTERVENTIONAL
Enrollment

201

Participants

Timeline

Start Date

October 7, 2019

Primary Completion Date

March 25, 2022

Study Completion Date

March 28, 2022

Conditions
OverweightObesity
Interventions
DRUG

Semaglutide

Participants will receive semaglutide s.c. once weekly for a dose escalation period of 16 weeks and a maintenance period of 52 weeks

OTHER

Placebo

Participants will receive semaglutide placebo s.c. once weekly for a total of 68 weeks

Trial Locations (37)

1060

Ordination Dr. Hanusch, Vienna

1090

UZ Brussel, Brussels

1200

Cliniques Universitaires Saint-Luc - Serv. Pédiatrie, Brussels

2650

UZA - UZ Antwerpen - Kinderziekenhuis, Edegem

3000

UZ Leuven - Kindergeneeskunde, Leuven

5020

Universitätsklinik für Kinder und Jugendheilkunde Haus E, Salzburg

8511

Fließer-Görzer [Ordination], Saint Stefan

10000

KBC Zagreb, Zavod za dječju endokrinologiju i dijabetes, Zagreb

14203

UBMD Peds-Div of Endo/Diabetes, Buffalo

15224

UPMC Child Hosp-Pittsburgh, Pittsburgh

21229

Barry J. Reiner, MD LLC, Baltimore

27610

WakeMed Childn Endo-Dbt_Raleig, Raleigh

43213

Aventiv Research Inc, Columbus

45419

PriMed Clinical Research, Dayton

51000

Klinički bolnički centar Rijeka, pedijatrija, Rijeka

54449

Marshfield Clinic, Marshfield

55414

University of Minnesota_CPOM, Minneapolis

57701

Monument Health Clinical Rsrch, Rapid City

58104

Valley Weight Loss Clinic, Fargo

72190

Consultorio de Endocrinología y Pediatría, Puebla City

83646

Solaris Clinical Research, Meridian

125373

RMAPE, Moscow

191036

City Children Endocrinology Center n.a. Raukhfus, Saint Petersburg

191144

SPSBHI City Children out-patient clinic #44, Saint Petersburg

344013

"FSBEI of Higher Education Rostov State Medical University", Rostov-on-Don

426009

Republic Children's Hospital of Ministry of Health of Udmurt, Izhevsk

630048

NSMU paediatric clinic, Novosibirsk

634050

Siberian State Medical University, Tomsk

02114-2621

Massachusetts General Hospital_Cary, Boston

10 000

"KBC Sestre Milosrdnice", Zagreb

D04 T6F4

Clinical Research Centre, St. Vincent's University Hospital,, Dublin

S65 1DA

Clifton Medical Centre, Rotherham

B4 6NH

Birmingham Children's Hospital, Birmingham

BS2 8AE

University Hospitals Bristol & Weston NHS Foundation Trust, Bristol

WC1E 6DB

Paediatric Services - UCL, London

S35 9XQ

Ecclesfield Group Practice, Sheffield

SO16 6YD

Southampton General Hospital, Southampton

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY

NCT04102189 - A Research Study on How Well Semaglutide Works in Adolescents With Overweight or Obesity | Biotech Hunter | Biotech Hunter